ABBV AbbVie Inc.

286.20USD+0.96%Mkt Cap: 505.89B USDP/E: 49.18

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimm…